exforge hct 10mg/160mg/25mg tablets film-coated
novartis pharma stein ag - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+ 160mg+ 25mg
exforge hct 10mg/160mg/12.5mg tablets film-coated
novartis pharma stein ag - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+ 160mg+ 12,5mg
exforge tablets film-coated
novartis farmaceutica s.a. - amlodipine (amlodipine besilate), valsartan - tablets film-coated - 10mg+ 160mg
exforge tablets film-coated
siegfried barbera s.l. - amlodipine (amlodipine besilate), valsartan - tablets film-coated - 10mg+ 160mg
exforge tablets film-coated
novartis farmaceutica s.a. - amlodipine (amlodipine besilate), valsartan - tablets film-coated - 5mg+ 160mg
exforge tablets film-coated
novartis farmaceutica s.a. - amlodipine (amlodipine besilate), valsartan - tablets film-coated - 5mg+ 80mg
exforge tablets film-coated
siegfried barbera s.l. - amlodipine (amlodipine besilate), valsartan - tablets film-coated - 5mg+ 160mg
exforge 5/320 amlodipine (as besilate) and valsartan 5/320mg film-coated tablet blister pack
novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; iron oxide yellow; crospovidone; sodium starch glycollate; colloidal anhydrous silica; hypromellose; purified talc; macrogol 4000; iron oxide red - exforge is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.
exforge hct 5mg/160mg/25mg tablets film-coated
novartis pharma stein ag - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 5mg+ 160mg+ 25mg
exforge 5 mg160 mg
novartis israel ltd - amlodipine as besylate; valsartan - film coated tablets - amlodipine as besylate 5 mg; valsartan 160 mg - amlodipine - amlodipine - treatment of essential hypertension. exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy.